Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

NCT04603508 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Dyslipidemia

Interventions

DRUG: BERLIM 25/10 association
DRUG: EMPAGLIFLOZIN
DRUG: ROSUVASTATIN CALCIUM
OTHER: BERLIM 25/10 ASSOCIATION PLACEBO
OTHER: EMPAGLIFLOZIN PLACEBO
OTHER: ROSUVASTATIN CALCIUM PLACEBO

Sponsor

EMS